Photon-counting detector CT in musculoskeletal imaging: benefits and outlook.
Authors
Affiliations (4)
Affiliations (4)
- Department of Radiology, Mayo Clinic, Rochester, MN.
- Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
- Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden.
- Department of Radiology, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Abstract
Photon-counting detector CT (PCD-CT) represents a significant advancement in medical imaging, particularly for musculoskeletal (MSK) applications. Its primary innovation lies in enhanced spatial resolution, which facilitates improved detection of small anatomical structures such as trabecular bone, osteophytes, and subchondral cysts. PCD-CT enables high-quality imaging with reduced radiation doses, making it especially beneficial for populations requiring frequent imaging, such as pediatric patients and individuals with multiple myeloma. Additionally, PCD-CT supports advanced applications like bone quality assessment, which correlates well with gold-standard tests, and can aid in diagnosing osteoporosis and assessing fracture risk. Techniques such as spectral shaping and virtual monoenergetic imaging further optimize the technology, minimizing artifacts and enhancing material decomposition. These capabilities extend to conditions like gout and hematologic malignancies, offering improved detection and assessment. The integration of artificial intelligence could enhance PCD-CT's performance by reducing image noise and improving quantitative assessments. Ultimately, PCD-CT's superior resolution, reduced dose protocols, and multi-energy imaging capabilities will likely have a transformative impact on MSK imaging, improving diagnostic accuracy, patient care, and clinical outcomes.